
|
 |
Nutritional Supplement |
 |
|
 |
 |
Megasol Q10®
References
-
O'Keefe JH
Jr, Harris WS. From Inuit to implementation: omega-3 fatty
acids come of age. Mayo Clin Proc 2000;75(6):607-14.
-
Mori TA,
Woodman RJ. The independent effects of eicosapentaenoic acid
and docosahexaenoic acid on cardiovascular risk factors in
humans. Curr Opin Clin Nutr Metab Care 2006;9(2):95-104.
-
De Caterina
R, Zampolli A, Del Turco S, Madonna R, Massaro M. Nutritional
mechanisms that influence cardiovascular disease. Am J Clin
Nutr 2006;83(2):421S-426S.
-
Harris WS.
Omega-3 long-chain PUFA and triglyceride lowering: minimum
effective intakes. Eur Heart J 2001;3:D59-D61.
-
Roche HM, Gibney MJ. Long-chain n-3 polyunsaturated fatty
acids and triacylglycerol metabolism in the postprandial state.
Lipids 1999;34(Suppl):S259-65.
-
Phillipson BE, Rothrock DW, Connor WE,
Harris WS,
Illingworth DR.
Reduction of plasma lipids, lipoproteins, and apoproteins by
dietary fish oils in patients with hypertriglyceridemia. N
Engl J Med 1985;312(19):1210-6.
-
GISSI Group. Dietary supplementation with n-3
polyunsaturated fatty acids and vitamin E after myocardial
infarction: results of the GISSI-Prevenzione trial. Lancet
1999;354(9177):447-55.
-
Burr ML,
Fehily AM, Gilbert JF, Rogers S,
Holliday RM,
Sweetnam PM, Elwood PC, Deadman NM.
Effects of changes in fat, fish, and fibre intakes on death and
myocardial reinfarction: diet and reinfarction trial (DART).
Lancet 1989;2(8666):757-61.
-
Albert CM,
Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J.
Blood levels of long-chain n-3 fatty acids and the risk of
sudden death. N Engl J Med 2002;346(15): 1113-8.
-
Albert CM,
Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC,
Ruskin JN, Manson JE. Fish consumption and risk of sudden
cardiac death. JAMA 1998; 279(1):65-6.
-
Siscovick
DS, Raghunathan TE, King I,
Weinmann S,
Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi
LH.
Dietary intake and cell membrane levels of long-chain n-3
polyunsaturated fatty acids and the risk of primary cardiac
arrest. JAMA 1995; 274(17):1363-7.
-
Vasudevan
AR, Jones PH. Effective use of combination lipid therapy.
Curr Atheroscler Rep 2006;8(1):76-84.
-
Chapidze G, Kapanadze S, Dolidze N, Bachutashvili Z,
Latsabidze N.
Prevention
of coronary atherosclerosis by the use of combination therapy
with antioxidant coenzyme Q10 and statins.
Georgian Med News 2005;(118):20-5.
-
Strey CH,
Young JM, Molyneux SL, George PM,
Florkowski CM,
Scott RS, Frampton CM.
Endothelium-ameliorating effects of statin therapy and coenzyme
Q10 reductions in chronic heart failure.
Atherosclerosis 2005;179(1):201-6.
|
 |
|